Stock Events

Stock Events

Mentari Therapeutics 

0
39
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

May 13Expected
Q1 2025
-17.34
-17
-16.67
-16.34
Expected EPS
N/A
Actual EPS
-17.336422

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MWG0.MU. It's not an investment recommendation.
Bitcoin
5
BTC.CRYPTO
AGNC Investment
5
AGNC
Meta Platforms
5
META
Gamestop
5
GME

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap81.62M
Corbus Pharmaceuticals specializes in the development of drugs targeting inflammatory and fibrotic diseases, overlapping with InMed's therapeutic areas.
Aurora Cannabis
ACB
Mkt Cap257.04M
Aurora Cannabis is a major player in the cannabis industry, whose expansion into medical cannabis products puts it in direct competition with InMed's pharmaceutical cannabis products.
Tilray Brands
TLRY
Mkt Cap373.9M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially competing with InMed in the medical cannabis market.
Canopy Growth
CGC
Mkt Cap276.03M
Canopy Growth Corporation operates in the cannabis and hemp business, competing with InMed in the development of cannabinoid-based pharmaceuticals.
Curaleaf
CURLF
Mkt Cap2.5B
Curaleaf Holdings operates in the cannabis retail and medical cannabis oil production, competing with InMed in the cannabinoid-based product market.

About

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Show More
CEO
Eric A. Adams Chem.
Employees
6
Country
Canada
ISIN
CA4576378091
WKN
000A42R7Q

Listings

MU
DE
MWG2.MU
F
DE
MWG.F
XNAS
US
INM
STU
DE
MWG.STU

0 Comments

Share your thoughts

FAQs

What is Mentari Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Mentari Therapeutics stocks are traded under the ticker MWG0.MU.
When is the next Mentari Therapeutics earnings date?▼
Mentari Therapeutics is going to release the next earnings report on February 16, 2027.
What were Mentari Therapeutics earnings last quarter?▼
MWG0.MU earnings for the last quarter are -17.34 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Mentari Therapeutics have?▼
As of November 7, 2026, the company has 6 employees.
In which sector is Mentari Therapeutics located?▼
Mentari Therapeutics operates in the Health & Wellness sector.
When did Mentari Therapeutics complete a stock split?▼
Mentari Therapeutics has not had any recent stock splits.
Where is Mentari Therapeutics headquartered?▼
Mentari Therapeutics is headquartered in VANCOUVER, Canada.